Ananda Developments - Extension of Mark Ling as Senior Statutory Auditor
RNS
Latest announcements
Announcement summary
Ananda Developments - Extension of Mark Ling as Senior Statutory Auditor
We've extended Mark Ling's term as Senior Statutory Auditor for the financial year ending 31 January 2024. This extension allows for continuity and expertise in navigating recent business changes.
The audit committee ensures compliance with audit quality standards, and the process to replace Mark Ling for the next audit period has begun. If you have any questions or would like more details about this announcement, feel free to ask us! Your involvement and interest in our company are appreciated.
Ask a question
Your question will be sent privately to Ananda Pharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Ananda Pharma a question about this announcement.